Emerging Infections Sentinel Networks
In its 1994 monograph, Addressing Emerging Infectious Disease Threats – A Prevention Strategy for the United States, the Centers for Disease Control and Prevention (CDC) called for the establishment of provider-based Emerging Infections Sentinel Networks (EISNs) to monitor and evaluate conditions that are not covered by health department surveillance and that are likely to be seen by specific kinds of health providers. There are currently three provider-based networks established through CDC’s EISN cooperative agreement programs: 1) Surveillance network of infectious disease specialists, 2) Global surveillance network of travel medicine clinics, and 3) Emergency department-based network of academically affiliated emergency departments for research on emerging infectious diseases. The first two networks (infectious disease specialists and travel medicine clinics) are non-research programs, and the third network (academically affiliated EDs) is a research program. These networks contribute to surveillance for emerging infectious diseases, including drug resistant, foodborne and waterborne, and vaccine-preventable or potentially vaccine-preventable diseases, and enhance information exchange leading to early identification of and response to trends and outbreaks.
Objectives for the provider-based sentinel networks include the following:
-To support linked groups of participating individuals or organizations in monitoring a variety of infectious disease problems and enhancing communication and collaboration among network members and the public health community;
-To serve as readily accessible mechanisms to address urgent public health infectious disease problems rapidly; and
-To improve understanding of specific public health issues, including, but not limited to, international travel, and enhance preparedness to meet new infectious disease threats among domestic and globally mobile populations.
Additional objectives for the "research" EISN include:
-To focus studies on the most important issues to be addressed by participating hospital EDs and CDC; and
-To estimate the community burden of diseases.
General information about this opportunity
Last Known Status
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Type(s) of Assistance Offered
Public Health Service Act Sections 301(a)[42 U.S.C.241(a)], 317(k)(1)[42 U.S.C.247b(k)(1)], and 317(k)(2)[42 U.S.C.247b(k)(2)], as amended.
Who is eligible to apply/benefit from this assistance?
Eligibility for this program is open, however, only institutions/organizations that meet and can demonstrate the necessary qualifications described in the published FOAs for this program should apply. Additional eligibility information is also described below:
There are both research and non-research funding opportunities under this program. For the research opportunity, only organizations currently operating a nationwide provider-based sentinel network that link academically affiliated hospital emergency departments in monitoring a variety of infectious disease problems are eligible. For the non-research opportunity, only organizations currently operating provider-based sentinel networks that link groups of participating individuals or organizations organized around either infectious disease clinicians or travel medicine in monitoring a variety of infectious disease problems are eligible. Applicants should refer to the published FOAs for more information regarding applicant eligibility.
- Health Professionals
- Anyone/general public.
Only organizations currently operating provider-based sentinel networks that link academically affiliated hospital emergency departments, or groups of participating individuals/organizations organized around either infectious disease clinicians or travel medicine, in monitoring a variety of infectious disease problems should submit an application. Applicants must provide documentation of the applicant’s qualifications, standing, and relationships in representing a group of academically affiliated hospital emergency departments or providers in a sentinel network. Include letters of support from network members. 2 CFR 200, Subpart E - Cost Principles applies to this program.
What is the process for applying and being award this assistance?
Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Detailed instructions regarding application procedures and requirements will be included in the published Funding Opportunity Announcements for this program.
Applications that are complete and responsive will be evaluated for scientific and technical merit by an Objective Review Panel (for the non-research funding opportunity) or a Special Emphasis Panel (SEP) (for the research funding opportunity) in accordance with CDC review policies and procedures. CDC will not review incomplete and non-responsive applications. Complete and responsive applications will undergo the appropriate review process (Objective Review or SEP Review), receive a written critique and be scored according to the published review criteria. Any deviation from this process will be detailed in the published FOA for this program.
Successful applicants will receive a Notice of Award (NOA) from the CDC Procurement and Grants Office. The NOA shall be the only binding, authorizing document between the recipient and CDC. The NOA will be signed by an authorized Grants Management Officer. Initial award provides funds for the first budget period (usually 12 months) and the NOA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any. Once competing applicants have been selected for the first year of funding in the project period, those selected will be eligible to submit annual non-competitive continuation applications for each successive budget period of the project period.
Contact the headquarters or regional office, as appropriate, for application deadlines.
Approval/Disapproval Decision Time
From 90 to 120 days.
From 60 to 90 days. Awards under this Program are typically issued for 1- to 5-year project periods. Renewals at the end of each project period are expected to be made available via publishing of a Renewal – Competing Continuation FOA with a complete application and review/award process as described above. Annual renewals within an awarded multi-year project period are made via a non-competitive process and are subject to the availability of funding.
How are proposals selected?
Applications will be reviewed against specific Evaluation Criteria published in the Funding Opportunity Announcements for this program.
How may assistance be used?
Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual. More detailed information regarding use of funding for specific projects/activities will be included in the published FOAs for this program. The full list of restrictions for this program are/will be included in the published Funding Opportunity Announcements for this program. General restrictions that apply are as follows:
-Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual.
-Awardees may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget.
-The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives an not merely serve as a conduit for an award to another party or provider who is ineligible.
What are the requirements after being awarded this opportunity?
Program reports are not applicable. No later than 10 days after the end of each calendar quarter, the recipients must submit a calendar quarter cash transaction report (SF-272 or top portion of the SF-425 Financial Report Form) to the Payment Management System (PMS). The reporting schedule is/will be based on the requirements listed in the published Funding Opportunity Announcements for this Program. Funded applicants must provide CDC with an Annual Progress Report (APR). Additionally, funded applicants must provide CDC with a Federal Financial Report (SF-425) no more than 90 days after the end of each budget period, and a final Performance and Federal Financial Report no more than 90 days after the end of the project period. All reports must be submitted to the Grants Management Specialist/Officer indicated in the NoA. Additional details regarding the reporting requirements for this program are/will be included in the published Funding Opportunity Announcements. Federal Financial Reports (SF-425) are due no more than 90 days after the end of each budget period. No performance monitoring is required.
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503.
Financial records, supporting documents, statistical records, and all other records pertinent to the grant program must be retained for a minimum of 3 years after the end of the budget period, or until completion and resolution of any audit in process or pending resolution. In all cases, records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42.
Other Assistance Considerations
Formula and Matching Requirements
This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance
Financial assistance is available for a 12-month budget period within project periods ranging from one to five years. Method of awarding/releasing assistance: lump sum.
Who do I contact about this opportunity?
Regional or Local Office
Susan Gantt 1600 Clifton Road NE, Mailstop C18, Atlanta, Georgia 30329 Email: SGantt@cdc.gov
(Cooperative Agreements) FY 14 $0; FY 15 est $0; and FY 16 est $1,500,000 - Initial obligations under this program will be made in FY 2016. EISN is a long existing program which, prior to this request for new CFDA, has been funded under 93.283.
Range and Average of Financial Assistance
Award Range: $300k–$800k
Average Award: $550k.
Regulations, Guidelines and Literature
Regulations governing this program are/will be published in the Funding Opportunity Announcements and identified on the notices of award. Regulations are also published under 42 CFR 55B. Guidelines are available under 45 CFR 92, and also HHS Grants Policy Statement at http://www.ahrq.gov/fund/hhspolicy.htm.
Examples of Funded Projects